Logo

Bluejay Diagnostics, Inc.

BJDX

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; a… read more

Healthcare

Medical Devices

4 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$0.94

Price

+9.57%

$0.08

Market Cap

$427.372k

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financial Reports

Key metrics over the past few years and other important metrics. Amounts in USD.

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$0.00

-

1y CAGR

-

3y CAGR

-25.0%

5y CAGR
Earnings

-$6.903m

-0.8%

1y CAGR

+11.0%

3y CAGR

+6.5%

5y CAGR
EPS

-$16.32

-7.0%

1y CAGR

+10.8%

3y CAGR

+8.3%

5y CAGR
Book Value

$4.181m

$5.599m

Assets

$1.417m

Liabilities

$100.520k

Debt
Debt to Assets

1.8%

-

Debt to EBITDA
Free Cash Flow

-$6.651m

-6.8%

1y CAGR

+8.8%

3y CAGR

+6.4%

5y CAGR
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases